Approval · Notice of Compliance 30609 · 2023
KANUMA: Notice of Compliance 30609
Issued April 28, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30609
- Date
- April 28, 2023
- Company
- Alexion Pharma GmbhBaar, --, Switzerland
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing facility for the drug substance. Changes to the manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KANUMA | Not yet assigned | — |
Medicinal ingredients
- SEBELIPASE ALFA 2 MG per ML